药学干预对糖尿病合并高血压患者的药学干预及临床治疗评价
|
摘要
目的:探究药学干预对糖尿病合并高血压患者的药学干预及临床治疗评价。方法:笔者选取本院于2017年1月～2018年6月收治的确诊为糖尿病合并高血压的患者130例,按随机原则,分为对照组(n=65,运用常规临床治疗的方法)和干预组(n=65,应用药学干预的方法),观察治疗后两组血糖(餐后2h血糖、空腹血糖)和血压(舒张压、收缩压),以及不良反应发生率和不合理药物使用率。结果:治疗后干预组的餐后2h血糖、空腹血糖、舒张压以及收缩压均较对照组降低,同时,干预组的不良反应发生率和不合理药物使用率较对照组下降,差异具有统计学意义(P<0.05)。结论:对糖尿病合并高血压采取药学干预可以有效地帮助降低血糖、控制血压并且减少不良反应发生率和不合理药物使用率。
Objective:To explore the evaluation of pharmaceutical intervention and clinical treatment in patients with diabetes mellitus and hypertension. Method:From January 2017 to June 2018,the author selected 130 cases of patients,diagnosed with diabetes and hypertension in our hospital. They were randomly divided into control group(n = 65,using conventional clinical treatment) and Intervention group(n = 65,using pharmaceutical intervention plan),observing the changes of blood glucose(2 h postprandial blood glucose,fasting blood glucose) and blood pressure(diastolic blood pressure,systolic blood pressure),as well as the incidence of adverse reactions and unreasonable drug use rate in the two groups after treatment. Result:After treatment,the 2 h postprandial blood glucose,fasting blood glucose,diastolic blood pressure and systolic blood pressure in the intervention group were lower than those in the control group. Meanwhile,the incidence of adverse reactions and unreasonable drug use rate in the intervention group were lower than those in the control group,and the above data were statistically significant(P<0.05). Conclusion:Pharmaceutical intervention for patients with diabetes and hypertension can effectively help patients to reduce blood glucose,control blood pressure and reduce the incidence of adverse reactions and unreasonable drug use rate,which is of guiding significance for clinical work.
Objective:To explore the evaluation of pharmaceutical intervention and clinical treatment in patients with diabetes mellitus and hypertension. Method:From January 2017 to June 2018,the author selected 130 cases of patients,diagnosed with diabetes and hypertension in our hospital. They were randomly divided into control group(n = 65,using conventional clinical treatment) and Intervention group(n = 65,using pharmaceutical intervention plan),observing the changes of blood glucose(2 h postprandial blood glucose,fasting blood glucose) and blood pressure(diastolic blood pressure,systolic blood pressure),as well as the incidence of adverse reactions and unreasonable drug use rate in the two groups after treatment. Result:After treatment,the 2 h postprandial blood glucose,fasting blood glucose,diastolic blood pressure and systolic blood pressure in the intervention group were lower than those in the control group. Meanwhile,the incidence of adverse reactions and unreasonable drug use rate in the intervention group were lower than those in the control group,and the above data were statistically significant(P<0.05). Conclusion:Pharmaceutical intervention for patients with diabetes and hypertension can effectively help patients to reduce blood glucose,control blood pressure and reduce the incidence of adverse reactions and unreasonable drug use rate,which is of guiding significance for clinical work.
引文
[1]高凤娟,杜学锋,史宇晖,等.全科医生签约服务在北京德胜社区原发性高血压病患者分级诊疗中的效果评价[J].中国全科医学,2018,21(9):1070-1074.
[2]姜嫄,张长海.老年充血性心力衰竭危险因素及药物干预后患者心功能的改善[J].中国老年学杂志,2018,38(13):3102-3105.
[3]朱冰坡,范利,蔺士杰,等.益阳地区成年体检人群高尿酸血症患病率及相关危险因素分析[J].中华保健医学杂志,2018,20(1):36-39.
[4]吴迪,李克明.半夏白术天麻汤合丹参酮对痰瘀阻络型糖尿病合并高血压患者干预作用的临床研究[J].世界中西医结合杂志,2018,13(3):414-417.
[5]李蓉.降低2型糖尿病心血管风险的药物管理手段[J].中华糖尿病杂志,2018,10(6):394-397.
[6]姜波,郭东风,姜素英.氯沙坦联合前列地尔治疗糖尿病肾病合并高血压疗效观察[J].医学临床研究,2018,35(9):1734-1736.
[7]杨伟,华琦.2型糖尿病心血管病变高血压管理的研究进展[J].医学综述,2017,23(6):1201-1205.
[8]蒋彬,吕建华.糖尿病合并高血压患者的药学干预及治疗评价分析[J].中国合理用药探索,2017,14(7):43-44,54.
[9]梁东亮,李小鹰,王林,等.21省市自治区门诊老年冠心病合并糖尿病患者ACEI/ARB类药物应用现况调查及影响因素分析[J].中华医学杂志,2016,96(36):2917-2922.
[2]姜嫄,张长海.老年充血性心力衰竭危险因素及药物干预后患者心功能的改善[J].中国老年学杂志,2018,38(13):3102-3105.
[3]朱冰坡,范利,蔺士杰,等.益阳地区成年体检人群高尿酸血症患病率及相关危险因素分析[J].中华保健医学杂志,2018,20(1):36-39.
[4]吴迪,李克明.半夏白术天麻汤合丹参酮对痰瘀阻络型糖尿病合并高血压患者干预作用的临床研究[J].世界中西医结合杂志,2018,13(3):414-417.
[5]李蓉.降低2型糖尿病心血管风险的药物管理手段[J].中华糖尿病杂志,2018,10(6):394-397.
[6]姜波,郭东风,姜素英.氯沙坦联合前列地尔治疗糖尿病肾病合并高血压疗效观察[J].医学临床研究,2018,35(9):1734-1736.
[7]杨伟,华琦.2型糖尿病心血管病变高血压管理的研究进展[J].医学综述,2017,23(6):1201-1205.
[8]蒋彬,吕建华.糖尿病合并高血压患者的药学干预及治疗评价分析[J].中国合理用药探索,2017,14(7):43-44,54.
[9]梁东亮,李小鹰,王林,等.21省市自治区门诊老年冠心病合并糖尿病患者ACEI/ARB类药物应用现况调查及影响因素分析[J].中华医学杂志,2016,96(36):2917-2922.